MediciNova, Inc. (MNOV)
1.65
+0.05
(+3.12%)
USD |
NASDAQ |
Feb 09, 13:06
MediciNova SG&A Expense (TTM) : 5.882M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Aldeyra Therapeutics, Inc. | 9.186M |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Alnylam Pharmaceuticals, Inc. | 1.181B |
| Savara, Inc. | 37.38M |
| BioMarin Pharmaceutical, Inc. | 973.41M |